808 results on '"Steeg, Patricia S."'
Search Results
52. Supplementary Figure 3 from Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner
53. Data from Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
54. Supplementary Data from Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2+ Breast Cancer Brain Metastasis
55. Supplementary Figures from Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis
56. Supplementary Methods from Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis
57. Supplementary Figure Legend from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
58. Figure S1 from Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines
59. Supplementary Tables 1 - 2 from Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner
60. Supplementary Figures from Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis
61. Supplementary Figure 2 from Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner
62. CCR Translation for This Article from Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
63. Data from Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines
64. Supplementary Table 1 from Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines
65. Supplementary Figures S1-S4 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
66. Supplementary Table 1 from Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis
67. Supplementary Data from Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
68. Supplementary Figures S1-S9 from Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
69. Supplementary Figure Legends from Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
70. Data from Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
71. Supplementary Figures 1-5 from Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition
72. Data from Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain
73. Supplementary Tables from Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
74. Supplementary Figure 1 from Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2
75. Supplementary Figures from Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
76. Data from Quantitative Assessment of the p53-Mdm2 Feedback Loop Using Protein Lysate Microarrays
77. Supplementary Figure 1 from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
78. Supplementary Table 1, Figure Legend from Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2
79. Data from Alterations in Gemin5 Expression Contribute to Alternative mRNA Splicing Patterns and Tumor Cell Motility
80. Supplementary Tables 1-4, Figure Legends 1-2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
81. Supplementary Table 2 from Alterations in Gemin5 Expression Contribute to Alternative mRNA Splicing Patterns and Tumor Cell Motility
82. Supplementary Table 3.3 from Alterations in Gemin5 Expression Contribute to Alternative mRNA Splicing Patterns and Tumor Cell Motility
83. Supplementary Figure 5 from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
84. Data from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
85. Supplementary Figures 1-6 from Molecular Basis for the Critical Role of Suppressor of Cytokine Signaling-1 in Melanoma Brain Metastasis
86. Supplementary Figure 6 from Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis
87. Supplementary Methods from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
88. Supplementary Figure 1 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
89. Data from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
90. Supplementary Figure 5 from Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis
91. Data from Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
92. Supplementary Figure 4 from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
93. Supplementary Figure 4 from Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis
94. Supplementary Figure 3 from Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis
95. Supplementary Figure 2 from Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis
96. Supplementary Figure 2 from Alterations in Gemin5 Expression Contribute to Alternative mRNA Splicing Patterns and Tumor Cell Motility
97. Supplementary Figure 2 from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
98. Supplementary Table 2 from Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain
99. Supplementary Figure 3 from Opposing Effects of Pigment Epithelium–Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
100. Supplementary Table 1 from Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.